U.S. flag

An official website of the United States government

Medicaid State Plan Amendments

A Medicaid and CHIP state plan is an agreement between a state and the Federal government describing how that state administers its Medicaid and CHIP programs. It gives an assurance that a state will abide by Federal rules and may claim Federal matching funds for its program activities. The state plan sets out groups of individuals to be covered, services to be provided, methodologies for providers to be reimbursed and the administrative activities that are underway in the state.

When a state is planning to make a change to its program policies or operational approach, states send state plan amendments (SPAs) to the Centers for Medicare & Medicaid Services (CMS) for review and approval. States also submit SPAs to request permissible program changes, make corrections, or update their Medicaid or CHIP state plan with new information.

Persons with disabilities having problems accessing the SPA PDF files may call 410-786-0429 for assistance.

Results

Displaying 2291 - 2300 of 15693

Massachusetts
This SPA is to adopt certain income disregards for the determinations of eligibility for the Medicare Savings Program (MSP) groups.
Approval Date: June 1, 2023
Effective Date: January 1, 2023

North Dakota
This amendment amends the State Plan to request an extension to the exemption for a Recovery Audit Contractor (RAC).
Approval Date: May 31, 2023
Effective Date: April 1, 2023
Topics: Program Administration

Colorado
This plan amendment intends to make the 90% reimbursement of net invoice for outpatient hospital physician-administered drugs permanent.
Approval Date: May 31, 2023
Effective Date: May 12, 2023

Virginia
To adopt the changes to the eligibility rules for the Former Foster Care Children eligibility group, as enacted by the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities (SUPPORT) Act, Pub. L. No. 115-217, section 1002.
Approval Date: May 31, 2023
Effective Date: January 1, 2023

New York
To include coverage and reimbursement for gambling treatment provided to individuals receiving services from the Office of Addiction Services and Supports (OASAS) certified services, pursuant to 14 NYCRR Part 818 Chemical Dependence Inpatient Services, 14 NYCRR Part 820 Residential Addiction Rehabilitation Services, 14 NYCRR Part 822 Outpatient Addiction Rehabilitation Services, 14 NYCRR Part 825 Integrated Outpatient Addiction Rehabilitation Services and 14 NYCRR Part 857, with the OASAS gambling designation, when services are for gambling disorder/problem gambling only.
Approval Date: May 31, 2023
Effective Date: March 1, 2023
Topics: Coverage and Reimbursement

Pennsylvania
CMS is approving this time-limited state plan amendment to allow the state to implement temporary policies while returning to normal operations after the COVID-19 national emergency.  The purpose of this amendment is to temporarily extend the Alternative Payment Methodology (APM) to pay Federally Qualified Health Centers (FQHC) and Rural Health Clinics (RHC) for COVID-19 vaccine administration.
Approval Date: May 26, 2023
Effective Date: May 12, 2023
Topics: Disaster Relief Reimbursement

Massachusetts
This SPA proposes to update the coverage language for certain nonprescription drugs on the state’s Pharmacy coverage pages.
Approval Date: May 25, 2023
Effective Date: January 1, 2023

Texas
This amendment is to expand the settings an ambulance provider may transport a beneficiary to from only a nursing facility or hospital to any appropriate setting.
Approval Date: May 25, 2023
Effective Date: September 1, 2022

New Jersey
To adopt the changes to the eligibility rules for the Former Foster Care Children eligibility group, as enacted by the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities (SUPPORT) Act, Pub. L. No. 115-217, section 1002.
Approval Date: May 25, 2023
Effective Date: January 1, 2023

South Dakota
This SPA proposes to update the coverage language for over-the-counter drugs.
Approval Date: May 25, 2023
Effective Date: April 1, 2023